Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.

MLA

Blumenthal, R. D., et al. “Comparison of Therapeutic Efficacy and Host Toxicity of Two Different 131I-Labelled Antibodies and Their Fragments in the GW-39 Colonic Cancer Xenograft Model.” International Journal of Cancer, vol. 44, no. 2, Aug. 1989, pp. 292–300. EBSCOhost, https://doi.org/10.1002/ijc.2910440218.

APA

Blumenthal, R. D., Sharkey, R. M., Kashi, R., & Goldenberg, D. M. (1989). Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model. International Journal of Cancer, 44(2), 292–300. https://doi.org/10.1002/ijc.2910440218

Chicago

Blumenthal, R D, R M Sharkey, R Kashi, and D M Goldenberg. 1989. “Comparison of Therapeutic Efficacy and Host Toxicity of Two Different 131I-Labelled Antibodies and Their Fragments in the GW-39 Colonic Cancer Xenograft Model.” International Journal of Cancer 44 (2): 292–300. doi:10.1002/ijc.2910440218.